Baotou Dongbao Bio-Tech Co.,Ltd (SHE:300239)
China
· Delayed Price · Currency is CNY 5.96
-0.06 (-1.00%)
Mar 11, 2026, 12:34 PM CST
SHE:300239 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 68.16 | 85.98 | 119.89 | 109.44 | 36.48 | 18.45 | Upgrade
|
| Depreciation & Amortization | 86.32 | 86.32 | 81.96 | 85.52 | 55.32 | 48.69 | Upgrade
|
| Other Amortization | 1.5 | 1.5 | 0.57 | 0.41 | 0.14 | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -1.47 | -1.47 | -0.08 | -0.14 | -0.09 | -0.01 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.88 | 0.88 | 0.86 | 0.42 | 0.6 | 0.11 | Upgrade
|
| Loss (Gain) From Sale of Investments | 3.74 | 3.74 | 4.33 | 1.91 | 2.53 | 0.84 | Upgrade
|
| Provision & Write-off of Bad Debts | -0.42 | -0.42 | 1.79 | 0.31 | 0.03 | -1.07 | Upgrade
|
| Other Operating Activities | 58.85 | 8.88 | 15.41 | 13.3 | 1.23 | 6.85 | Upgrade
|
| Change in Accounts Receivable | -11.73 | -11.73 | -52.76 | -45.13 | -62.48 | 27.91 | Upgrade
|
| Change in Inventory | -72.34 | -72.34 | 37.86 | 28.36 | 6.38 | -55.23 | Upgrade
|
| Change in Accounts Payable | -37.62 | -37.62 | -3.01 | 5.31 | 14.41 | 20.29 | Upgrade
|
| Change in Other Net Operating Assets | 3.35 | 3.35 | -3.51 | -0.99 | -2.93 | -1.83 | Upgrade
|
| Operating Cash Flow | 101.28 | 69.13 | 199.39 | 195.32 | 51.5 | 63.13 | Upgrade
|
| Operating Cash Flow Growth | 2.95% | -65.33% | 2.09% | 279.25% | -18.42% | - | Upgrade
|
| Capital Expenditures | -64.63 | -77.17 | -132.24 | -108.56 | -51.35 | -151.93 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.14 | 34.08 | 0.24 | 0.82 | 0.95 | 0.03 | Upgrade
|
| Cash Acquisitions | -232 | -232 | - | -122.34 | -108.07 | - | Upgrade
|
| Investment in Securities | 116 | 0 | - | 4.67 | -11.53 | -7.09 | Upgrade
|
| Other Investing Activities | 6.63 | 9.04 | 1.59 | 1.24 | 1.57 | - | Upgrade
|
| Investing Cash Flow | -173.86 | -266.05 | -130.41 | -224.17 | -168.44 | -158.99 | Upgrade
|
| Short-Term Debt Issued | - | 1.27 | 29 | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | 3 | 447.05 | 210.05 | 84.8 | 147.8 | Upgrade
|
| Total Debt Issued | 55.67 | 4.27 | 476.05 | 210.05 | 84.8 | 147.8 | Upgrade
|
| Long-Term Debt Repaid | - | -8 | -147.98 | -67.1 | -209.8 | -41.5 | Upgrade
|
| Net Debt Issued (Repaid) | 6.34 | -3.73 | 328.06 | 142.95 | -125 | 106.3 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 398.14 | - | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | -2.69 | -2.58 | Upgrade
|
| Common Dividends Paid | -17.97 | -15.81 | -21.28 | -11.21 | -5.73 | -20.6 | Upgrade
|
| Other Financing Activities | -56.72 | 1.12 | -0.91 | 43.35 | -3.68 | 6.5 | Upgrade
|
| Financing Cash Flow | -68.35 | -18.42 | 305.87 | 175.08 | 261.04 | 89.62 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.01 | 0 | 0.14 | 0.34 | -0.01 | - | Upgrade
|
| Net Cash Flow | -140.93 | -215.34 | 374.99 | 146.58 | 144.08 | -6.24 | Upgrade
|
| Free Cash Flow | 36.65 | -8.04 | 67.15 | 86.76 | 0.15 | -88.8 | Upgrade
|
| Free Cash Flow Growth | - | - | -22.60% | 57752.55% | - | - | Upgrade
|
| Free Cash Flow Margin | 4.67% | -0.91% | 6.89% | 9.20% | 0.02% | -19.79% | Upgrade
|
| Free Cash Flow Per Share | 0.06 | -0.01 | 0.11 | 0.15 | - | -0.17 | Upgrade
|
| Cash Income Tax Paid | 42.42 | 39.64 | 79.94 | 68.11 | 34.92 | 15.32 | Upgrade
|
| Levered Free Cash Flow | -129.63 | -9.82 | 120.69 | -48.26 | -20.87 | -144.32 | Upgrade
|
| Unlevered Free Cash Flow | -127.29 | -8.22 | 123.9 | -43.49 | -17.88 | -140.66 | Upgrade
|
| Change in Working Capital | -116.28 | -116.28 | -25.33 | -15.84 | -44.74 | -10.73 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.